Adolescent and young adult research across the HIV prevention and care continua: an international programme analysis and targeted review.


Journal

Journal of the International AIDS Society
ISSN: 1758-2652
Titre abrégé: J Int AIDS Soc
Pays: Switzerland
ID NLM: 101478566

Informations de publication

Date de publication:
03 2023
Historique:
received: 19 01 2022
accepted: 30 01 2023
entrez: 23 3 2023
pubmed: 24 3 2023
medline: 25 3 2023
Statut: ppublish

Résumé

Human immunodeficiency virus (HIV) continues to rise in young people among low- and middle-income countries (LMIC). The US National Institutes of Health (NIH) supports the largest public investment in HIV research globally. Despite advancements in the last decade, adolescents and young adults (AYA) remain underrepresented in research to improve HIV prevention and care. We undertook a programme analysis of NIH grants and conducted a targeted review of linked publications on international AYA research across the HIV prevention and care continuum (HPCC) to inform new initiatives to address the needs of AYA in these settings. NIH-funded grants from 2012 to 2017, pertaining to AYA in LMIC, and evaluating areas of HIV prevention, care and/or treatment were identified. A systematic review of publications limited to funded grants was performed in two waves: 2012-2017 and 2018-2021. The review included a landscape assessment and an evaluation of NIH-defined clinical trials, respectively. Data on outcomes across the HPCC were abstracted and analysed. Among grant applications, 14% were funded and linked to 103 publications for the analytic database, 76 and 27 from the first and second waves, respectively. Fifteen (15%) wave 1 and 27 (26%) wave 2 publications included an NIH-defined clinical trial. Among these, 36 (86%) did not target a key population (men who have sex with men, drug users and sex workers) and 37 (88%) were exclusively focused on sub-Saharan Africa. Thirty (71%) publications addressed at least one HPCC milestone. Specific focus was on milestones in HIV prevention, care or both, for 12 (29%), 13 (31%) and five (12%) of publications, respectively. However, few addressed access to and retention in HIV care (4 [14%]) and none included microbicides or treatment as prevention. More focus is needed in crucial early steps of the HIV care continuum and on biomedical HIV prevention interventions. Research gaps remain in this portfolio across the AYA HPCC. To address these, NIH launched an initiative entitled Prevention and Treatment through a Comprehensive Care Continuum for HIV-affected Adolescents in Resource Constrained Settings (PATC

Identifiants

pubmed: 36951058
doi: 10.1002/jia2.26065
pmc: PMC10034634
doi:

Types de publication

Systematic Review Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e26065

Informations de copyright

© 2023 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of the International AIDS Society.

Références

J Int AIDS Soc. 2016 Nov 17;19(1):21263
pubmed: 27863535
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
Clin Infect Dis. 2007 Mar 15;44(6):874-8
pubmed: 17304463
Lancet Child Adolesc Health. 2018 Jun;2(6):e12
pubmed: 30169288
AIDS Patient Care STDS. 2013 Dec;27(12):692-6
pubmed: 24073595
J Int AIDS Soc. 2015 Sep 16;18:20049
pubmed: 26385853
J Int AIDS Soc. 2013 Jun 18;16:18579
pubmed: 23782477
Curr Opin HIV AIDS. 2018 May;13(3):170-178
pubmed: 29432227
J Int AIDS Soc. 2016 Nov 21;19(1):21098
pubmed: 27876454
AIDS Res Ther. 2016 Nov 8;13:35
pubmed: 27826353
Clin Infect Dis. 2011 Mar 15;52(6):793-800
pubmed: 21367734
Indian J Sex Transm Dis AIDS. 2010 Jan;31(1):1-10
pubmed: 21808429
N Engl J Med. 2015 Feb 5;372(6):509-18
pubmed: 25651245
J Int AIDS Soc. 2015 Dec 02;18(Suppl 6):20257
pubmed: 26639113
Healthcare (Basel). 2020 Aug 03;8(3):
pubmed: 32756349
N Engl J Med. 2012 Aug 2;367(5):411-22
pubmed: 22784040
N Engl J Med. 2010 Dec 30;363(27):2587-99
pubmed: 21091279
J Acquir Immune Defic Syndr. 2020 May 1;84(1):92-100
pubmed: 32267659
J Behav Med. 1990 Jun;13(3):245-61
pubmed: 2213868
J Am Med Inform Assoc. 2011 Jul-Aug;18(4):423-31
pubmed: 21527408
AIDS Care. 2015;27 Suppl 1:47-58
pubmed: 26616125
J Int AIDS Soc. 2013 Jun 18;16:18555
pubmed: 23782474
PLoS Med. 2010 Feb 02;7(2):e1000178
pubmed: 20126383
J Acquir Immune Defic Syndr. 2018 Jan 1;77(1):110-117
pubmed: 28991884
BMC Infect Dis. 2021 Jan 13;21(1):60
pubmed: 33435861
J Acquir Immune Defic Syndr. 2014 Jul 1;66 Suppl 2:S154-69
pubmed: 24918591
Lancet HIV. 2021 Dec;8(12):e766-e775
pubmed: 34856180
Pediatr Ann. 2017 May 1;46(5):e198-e202
pubmed: 28489226
JAMA Pediatr. 2015 Jul;169(7):619-20
pubmed: 25985061
Lancet Child Adolesc Health. 2018 Mar;2(3):214-222
pubmed: 30169256

Auteurs

Samantha Calabrese (S)

Maternal and Pediatric Infectious Disease Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA.

Matt Perkins (M)

Office of Portfolio Analysis, Division of Program Coordination, Planning, and Strategic Initiatives, Office of the Director, National Institutes of Health, Bethesda, Maryland, USA.

Sonia Lee (S)

Maternal and Pediatric Infectious Disease Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA.

Susannah Allison (S)

Developmental and Clinical Neuroscience of HIV Prevention and Treatment Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland, USA.

Gina Brown (G)

Office of AIDS Research, National Institutes of Health, Bethesda, Maryland, USA.
Medical Affairs, HIV Prevention, Gilead Sciences, Inc., New York City, New York, USA.

Patrick Jean-Philippe (P)

Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

Nahida Chakhtoura (N)

Maternal and Pediatric Infectious Disease Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA.

Jack Moye (J)

Maternal and Pediatric Infectious Disease Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA.

Bill G Kapogiannis (BG)

Maternal and Pediatric Infectious Disease Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH